Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection | PNAS
JKMS :: Journal of Korean Medical Science
boceprevir
Boceprevir | C27H45N5O5 - PubChem
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00367K
Boceprevir - an overview | ScienceDirect Topics
Mechanism of action of antiviral therapies
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses | ACS Infectious Diseases
Figure 2 from Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. | Semantic Scholar
Molecules | Free Full-Text | Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study | HTML
Research
Direct Acting Anti-hepatitis C Virus Drugs: Clinical Pharmacology and Future Direction. - Abstract - Europe PMC
Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections: Trends in Pharmacological Sciences
Discovery of Boceprevir, a Ketoamide-Derived HCV NS3 Protease Inhibitor, for Treatment of Genotype 1 Infections | SpringerLink
Victrelis (Boceprevir Capsules): Uses, Dosage, Side Effects, Interactions, Warning
Telaprevir mechanism of action. | Download Scientific Diagram
Boceprevir and telaprevir in beta-CoV infections. A) The cytotoxicity... | Download Scientific Diagram
The hepatitis C virus life cycle. | Download Scientific Diagram
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00367K
Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow - Asselah - 2012 - Liver International - Wiley Online Library
![PDF] Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f574dae05b487d1a964da310618f0b7e086e6217/5-Figure5-1.png "PDF] Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. | Semantic Scholar")
PDF] Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection. | Semantic Scholar
Solved What is the mechanism of action of Harvoni | Chegg.com
Mechanisms of action for direct-acting antivirals, currently in... | Download Scientific Diagram
An update on emerging therapeutics to combat COVID‐19 - Shah - 2021 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
A) Structures of boceprevir and telaprevir. (B) Three-dimensional... | Download Scientific Diagram
